Azenta to Participate in the Cowen 42nd Annual Health Care Conference
Azenta, Inc. (Nasdaq: AZTA) will participate in Cowen's 42nd Annual Health Care Conference on March 8, 2022, with a live presentation at 2:10 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) will participate in Cowen's 42nd Annual Health Care Conference on March 8, 2022, with a live presentation at 2:10 PM ET. The conference will be held virtually, and interested parties can access the live webcast via the Azenta investor relations website. A replay will be available after the event. Azenta is a global leader in life sciences solutions, providing cold-chain sample management and genomic services to the pharmaceutical and biotech industries.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was +2.58%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., Feb. 25, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Cowen's 42nd Annual Health Care Conference on Tuesday, March 8, 2022, which includes a presentation beginning at 2:10pm ET. The conference will be held in a virtual environment. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Azenta Life Sciences
978.262.2635
sara.silverman@azenta.com
Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-cowen-42nd-annual-health-care-conference-301490449.html
SOURCE Azenta
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.